FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to salt of 2-ethyl-6-methyl-3-hydroxypyridine with carnitine hydrate of formula I, for use in various fields of medicine for the correction of metabolic and cardiovascular disorders under the effect of oxidative stress. Invention also relates to a method of producing salt of 2-ethyl-6-methyl-3-hydroxypyridine with a carnitine hydrate of formula I. Method is carried out by boiling mixture of 2-ethyl-6-methyl-3-hydroxypyridine base and carnitine in an equimolar ratio, in water-ethanol solution. Then one performs cooling and the target crystalline product is separated by filtration.
EFFECT: salt of 2-ethyl-6-methyl-3-hydroxypyridine with carnitine hydrate, having antioxidant activity.
2 cl, 6 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIOXIDANT, PHOTOPROTECTIVE AND GEROPROTECTIVE AGENT | 2011 |
|
RU2458714C1 |
| DERIVATIVE OF 3-HYDROXYPYRIDINE WITH ANXIOLYTIC AND NOOTROPIC EFFECT | 2017 |
|
RU2664453C1 |
| AGENT POSSESSING NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2701739C1 |
| COMPLEX CONNECTION OF 5-HYDROXY-3,6-DIMETHYLURACYL WITH SUCCINIC ACID EXHIBITING MEMBRANE-STABILIZING ACTIVITY AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2631238C1 |
| METHOD FOR PREVENTING AND CORRECTING METABOLIC AND FUNCTIONAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM UNDER STRESS CONDITIONS | 2019 |
|
RU2717107C1 |
| METHOD FOR PRODUCING PLATINUM COMPLEXES (IV) WITH AMINONITROXYLE RADICALS | 2015 |
|
RU2613513C2 |
| NEUROPROTECTIVE AGENT | 2021 |
|
RU2765956C1 |
| 9-SUBSTITUTED-2-BIPHENYLIMIDAZO[1,2-A]BENZIMIDAZOLES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, HAVING ANTIOXIDANT AND ANTIRADICAL PROPERTIES | 2017 |
|
RU2649979C1 |
| AGENT FOR TREATMENT OF DISEASE CAUSED BY OXIDATIVE STRESS | 2018 |
|
RU2674286C1 |
| OMEGA-(HYDROXYARYL) ALKYLSULPHIDES BASED ON 2-IZOBORNYL-6-METHYL-4-PROPYLPHENOL | 2016 |
|
RU2616618C1 |
